Aladağ, N.Akdemir, Z.Çallı, I.2025-05-102025-05-1020231301-088310.5505/ejm.2023.802702-s2.0-85174459414https://doi.org/10.5505/ejm.2023.80270https://hdl.handle.net/20.500.14720/3160We report a unique case of superior mesenteric artery embolism that developed in a patient with COVID-19 who was followed up with the diagnosis of Fabry Disease. On the 12th day of COVID-19 illness, atrial fibrillation and superior mesenteric artery embolism were detected in a 56-year-old male patient who was previously diagnosed with Fabry Disease. We did not find a similar patient in the literature. In the coexistence of Fabry Disease and COVID-19, risk of arrhythmia such as atrial fibrillation, which is the most common arrhythmia in both diseases, increases further. COVID-19 can cause arterial and venous thrombosis. In the coexistence of Fabry Disease and COVID-19, care should be taken against increased thrombogenicity, arrhythmia (such as atrial fibrillation) and thromboembolism that may develop due to them. © 2023, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.eninfo:eu-repo/semantics/openAccessAtrial FibrilationCovid-19EmbolismFabry DiseaseSuperior Mesenteric ArteryArticle284N/AQ48328351263567